Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

AI helps spot pancreatic cancer over a year before radiologists can

AI model bests radiologists at detecting early signs of pancreatic cancer

The AI framework was designed to identify radiomic signatures of pre-diagnostic pancreatic ductal adenocarcinoma on CT.

Rochester Regional Health eyes imaging, oncology expansion

Hospital system pours $20M into expanding imaging, oncology services

Leaders with the New York organization hope the project will help improve care coordination for those who need it the most. 

Thumbnail

Multibillion-dollar deal brings together major industry players to develop 'next gen' radiopharmaceuticals

The joint venture is intended to advance cancer diagnostics and treatment, with the potential to rake in over $4 billion, those involved estimate.  

liver cancer

Interventional radiologist 1st in world to deliver newly approved cancer treatment

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.

Thumbnail

Treatment-related cancers on the rise, new study suggests

Therapy-related acute myeloid leukemia is an aggressive form of blood cancer and bone marrow that occurs in the years following radiation and chemotherapy. 

prostate cancer PSA

MRI-guided ablation as effective as surgery for prostate cancer treatment

A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors. 

money maze payment reimbursement

AI-enabled lesion quantification tool earns new CPT code

The software gives clinicians detailed insight into how patients are responding to treatment based on changes in lesion size and metabolic activity, offering earlier opportunities to alter care plans.  

prostate cancer PSA

One PSMA agent outshines competitors at detecting prostate cancer recurrence

An ongoing study is evaluating how capably two PSMA agents assess urinary radioactivity and identify smaller lesions in post-prostatectomy patients with low PSA biochemical recurrence.